Cychlorphine: What to Know About The New Synthetic Opioid

In recent years, the illicit drug supply in the United States has grown increasingly unpredictable. Alongside well-known substances like fentanyl and heroin, a new synthetic opioid—cychlorphine—has begun to raise concern among public health officials, law enforcement agencies, and forensic science researchers. As overdose deaths continue to rise across multiple states, providers like Eleve Behavioral Health are working to increase awareness, improve access to treatment, and help communities respond to emerging drug threats.

What Is Cychlorphine?

Cychlorphine is a highly potent synthetic opioid that interacts with opioid receptors in the brain, producing effects similar to other opioids such as fentanyl and heroin. While still relatively new in terms of detection and study, cychlorphine has already been linked to fatal overdoses and is considered extremely potent—even compared to fentanyl.

The compound is sometimes referred to as n-propionitrile chlorphine or propionitrile chlorphine, reflecting aspects of its chemical structure. Like other synthetic opioids, cychlorphine is not approved for medical use and is believed to be produced illicitly.

Clinicians at Eleve Behavioral Health emphasize that its extreme potency means that even very small doses can result in an opioid overdose, particularly when individuals are unaware of its presence in the drug supply.

Why Is Cychlorphine So Dangerous?

One of the primary concerns surrounding cychlorphine is its potency. Early forensic science research suggests that it may be several times stronger than fentanyl, placing it among the most dangerous substances currently circulating.

This extreme potency increases overdose risk in several ways:

• Unpredictable dosing: Users may unknowingly consume cychlorphine when it is mixed with other substances such as methamphetamine, cocaine, or heroin.
• Multiple doses required for reversal: Standard overdose response measures, including naloxone, may require multiple doses due to the strength of the drug.
• Rapid onset: Cychlorphine can quickly suppress breathing, increasing the likelihood of fatal overdoses.

Providers at Eleve Behavioral Health note that even individuals with a history of opioid use face heightened risk when exposed to this new synthetic opioid.

Where Has Cychlorphine Been Detected?

Cychlorphine has been identified in a growing number of suspected cases across multiple states, with particular concern in regions such as East Tennessee. In Knox County and surrounding counties, officials reported the presence of cychlorphine during overdose investigations beginning in March in recent years.

Local law enforcement agencies and public health officials have highlighted the detection of cychlorphine in mixed drug samples, often alongside fentanyl and other opioids. These findings suggest that the substance is entering the illicit drug supply without users’ knowledge.

Reports indicate that cychlorphine has been:[1]

• Detected in overdose cases involving multiple substances
• Linked to fatal overdoses in East Tennessee
• Identified through specialized testing conducted by forensic laboratories

Because standard drug testing may not detect emerging synthetic opioids, experts at Eleve Behavioral Health caution that their true presence in the drug supply may be underreported.

The Role of Forensic Science and Detection

The emergence of cychlorphine highlights the critical role of forensic science research in identifying new synthetic substances. Detection often requires specialized testing methods, as traditional toxicology screens may not identify compounds like cychlorphine.

Investigators and researchers rely on advanced techniques to confirm its presence in biological samples and seized substances. These efforts help:

• Track the spread of emerging synthetic opioids
• Support overdose investigations
• Inform public health responses

According to treatment professionals at Eleve Behavioral Health, improved detection is essential for timely intervention and prevention.

Cychlorphine and Overdose Deaths

The United States continues to face a severe opioid crisis. According to the Centers for Disease Control and Prevention (CDC), more than 100,000 overdose deaths have been reported annually in recent years, with synthetic opioids—primarily fentanyl—driving the majority of fatalities.[2]

The introduction of cychlorphine adds another layer of risk. While national data remains limited, early reports suggest that it has already been linked to fatal overdoses in several regions.

According to the Tennessee Department of Health, “Cychlorphine is a synthetic opioid, 10 times more potent than fentanyl. Fentanyl was associated with more than 1,633 fatal overdoses (TDH provisional data) in Tennessee in 2024.”[1]

Healthcare providers, including those at Eleve Behavioral Health, are increasingly concerned about a growing number of deaths involving multiple substances where cychlorphine appears to be a contributing factor.

How Cychlorphine Enters the Drug Supply

Like fentanyl, cychlorphine is believed to be produced illicitly and introduced into the drug supply as an additive or substitute. It may be:

• Mixed with heroin to increase potency
• Added to counterfeit pills
• Combined with stimulants such as methamphetamine or cocaine

This mixing significantly increases overdose risk. Individuals may unknowingly consume a highly potent opioid, even if they are not intentionally using one.

Professionals at Eleve Behavioral Health stress that this unpredictability is one of the most dangerous aspects of the current drug landscape.

Comparing Cychlorphine to Other Opioids

Cychlorphine belongs to a broader class of synthetic opioids that includes fentanyl and its analogs. However, it may be even more potent than fentanyl, which is already estimated to be 50–100 times stronger than morphine.

Key differences include:

• Potency: Potentially several times stronger than fentanyl
• Detection challenges: Requires specialized testing
• Limited research: Less is known about long-term effects

Despite these differences, cychlorphine affects the brain in similar ways, binding to opioid receptors and causing respiratory depression.

Recognizing an Opioid Overdose

Recognizing the signs of an opioid overdose is critical, especially with the rise of highly potent substances like cychlorphine. Symptoms may include:[3]

• Slow or stopped breathing
• Unconsciousness
• Pinpoint pupils
• Bluish lips or skin

Experts at Eleve Behavioral Health emphasize that immediate medical attention is essential in any suspected overdose.

Overdose Response and Naloxone

Naloxone is a life-saving medication that can reverse opioid overdoses. It works by blocking opioids from binding to receptors in the brain.

However, in cases involving extremely potent substances like cychlorphine, multiple doses may be required. First responders and community members should:

• Administer naloxone immediately
• Call emergency services
• Provide additional doses if needed

Clinicians at Eleve Behavioral Health highlight that naloxone remains effective, but rapid response is critical.

Public Health and Law Enforcement Response

The appearance of cychlorphine has prompted coordinated efforts among public health officials, law enforcement, and researchers. These efforts include:

• Increasing awareness of emerging synthetic opioids
• Enhancing detection and testing
• Sharing data across jurisdictions

Organizations like Eleve Behavioral Health play a key role by supporting individuals at risk and providing access to evidence-based treatment.

Why Awareness Matters

Awareness is one of the most important tools in addressing the risks associated with new synthetic opioids. Individuals should understand that:

• The drug supply is increasingly unpredictable
• Substances may be mixed without their knowledge
• Even a single dose can be fatal

Education and outreach efforts, including those led by Eleve Behavioral Health, are essential for reducing overdose deaths.

Harm Reduction and Support

Several steps can help reduce harm:

• Carry naloxone
• Avoid using substances alone
• Use drug testing when available
• Seek professional treatment

Treatment providers such as Eleve Behavioral Health offer support for individuals struggling with opioid use, including therapy, medication-assisted treatment, and long-term recovery planning.

The Need for Continued Research

Because cychlorphine is a relatively new synthetic opioid, ongoing research is needed to better understand its effects and improve response strategies.

Healthcare providers and researchers—including those collaborating with organizations like Eleve Behavioral Health—continue to monitor its presence and impact.

Get Connected to Treatment for Cychlorphine Addiction

Cychlorphine represents a serious and evolving threat within the illicit drug supply. Its extreme potency, difficulty of detection, and links to fatal overdoses highlight the need for vigilance.

Through increased awareness, improved detection, and access to treatment, communities can better respond to emerging synthetic opioids. Providers like Eleve Behavioral Health remain committed to supporting individuals, reducing overdose risk, and helping save lives.

Contact Eleve Behavioral Health today to learn more about how we can help you overcome opioid addiction and regain control over your life.

Frequently Asked Questions (FAQs)

1. How is cychlorphine different from other emerging synthetic opioids?

Cychlorphine is considered an emerging synthetic opioid with a distinct chemical structure that sets it apart from more commonly known substances like fentanyl analogs. While many synthetic opioids share similar effects, cychlorphine appears to have an unusually high potency and may behave differently in the body. This makes it more difficult for researchers and investigators to predict its full impact, increasing concern among forensic science and public health professionals.

2. Why are newer substances like cychlorphine hard to detect in standard drug tests?

Many routine drug tests are designed to detect known substances such as fentanyl, heroin, or prescription opioids. New synthetic compounds like cychlorphine often require specialized testing methods because their chemical makeup is not yet included in standard screening panels. This delay in detection can complicate overdose investigations and limit awareness of how widespread the substance has become.

3. Are certain populations at higher risk of exposure to cychlorphine?

Yes. Individuals who use illicit substances—especially those who use opioids or stimulants like methamphetamine or cocaine—may be at higher risk due to the increasing likelihood of drugs being mixed. However, risk is not limited to those intentionally using opioids. Because cychlorphine can be present in mixed substances, even occasional or non-opioid users may be exposed unknowingly.

4. What should someone do if they suspect a substance contains cychlorphine?

If there is any concern that a substance may contain a highly potent opioid like cychlorphine, it is safest not to use it. If exposure is suspected, individuals should ensure naloxone is available and avoid using it alone. Seeking guidance from healthcare providers or support organizations such as Eleve Behavioral Health can also help individuals better understand risks and access harm reduction resources.

5. How are communities responding to the rise of new synthetic opioids?

Communities are increasingly focusing on rapid information sharing, improved forensic detection, and expanded access to overdose prevention tools. Public health agencies, law enforcement, and treatment providers—including Eleve Behavioral Health—are working together to monitor trends, educate the public, and provide timely support for those affected.

6. What treatment options are available for someone affected by synthetic opioid use?

Treatment for synthetic opioid use is similar to treatment for other forms of opioid use disorder. This often includes medication-assisted treatment (MAT), behavioral therapy, and ongoing support services. Programs offered by providers like Eleve Behavioral Health are designed to address both the physical and psychological aspects of opioid use, helping individuals stabilize and move toward recovery.

References:

1. Tennessee Department of Health: TDH Reinforces Importance of Naloxone with Rise in Cychlorphine Fatalities
2. The Centers for Disease Control and Prevention (CDC): About Overdose Prevention
3. The National Library of Medicine (NLM): Opioid Toxicity